Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months
Analysts remain relatively more upbeat, but this could prove fleeting.
Overview
Boston Scientific (NYSE: BSX) shares have performed poorly in recent months. Year to date, shares in the medtech company have fallen by over 50%.
It's not surprising shares have fallen so far, so fast. Boston Scientific has kept walking back growth expectations all year. However, with the analyst community far more upbeat about it than the market, let's explore this beaten-down healthcare stock's comeback potential.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.